> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Oversight of Influencer Social Media Posts Hard: Researchers
- URL: https://www.fdaweb.com/oversight-of-influencer-social-media-posts-hard-researchers/
- Published: 2025-11-13T12:00:00.000Z
- Updated: 2026-09-14T15:26:30.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5160215

University of Chicago researchers say that while the federal government has proposed expanding direct-to-consumer ad oversight to include influencer partnerships and sponsored content, “effective oversight will be challenging because promotion is driven by thousands of individual creators rather than a few dozen companies.” Writing in a *JAMA Research Letter*, the authors [say](https://jamanetwork.com/journals/jama/fullarticle/2841349?guestAccessKey=4bed78de-86df-4493-855a-2243e743692d&utm%5Fmedium=email&utm%5Fsource=postup%5Fjn&utm%5Fcampaign=article%5Falert-jama&utm%5Fcontent=olf-tfl%5F&utm%5Fterm=111325) they conducted a content analysis of 740 high-engagement, regulator-relevant social media posts from 2023 that had amassed more than 57.5 million views as of 1/2025\. The posts were from Facebook, Instagram, TikTok, and YouTube, and discussed GLP-1 agonists, attention deficit disorder/hyperactivity disorder stimulants, or autoimmune biologics.

Overall, the researchers report, 175 posts (23.6%) used promotional language, with prevalence ranging from 14.4% on TikTok to 33% on Instagram. Some 116 posts (15.7%) included specific calls to action, with prevalence ranging from 6.1% on TikTok to 23.1% on Instagram.

“Despite these marketing elements,” the article says, “explicit disclosures of sponsorship using sponsored tags were rare, appearing in only 16 posts overall, ranging from 0.5% on YouTube to 4.7% on Facebook.”

The researchers found that with all factors combined, undisclosed influencer promotion was present in at least 593 (80.1%) of the high-engagement social media posts. “When reviewing all posts for fair balance,” they say, “efficacy claims were made in 511 posts (69.1%). In contrast, information on risks or adverse effects was mentioned in 247 (33.4%) of all 740 posts. Among the 511 posts making efficacy claims, only 165 (32.3%) also included any information on risks or adverse effects, creating a skewed information environment for patients.”